Stephanie Trunk’s Insights

330 total results. Page 8 of 28.

Health Care Counsel Blog
Texas Medicaid Program – Update for Drug Manufacturers
Health Care Counsel Blog
Health Resources and Services Administration Enjoined from Implementing the 340B Dispute Resolution Rule
Health Care Counsel Blog
Passage of American Rescue Plan Act of 2021 Could Mean Larger Medicaid Drug Rebate Program Rebates for Pharmaceutical Manufacturers
Health Care Counsel Blog
Arent Fox's Stark & Anti-Kickback Statute Final Rules Analysis
Alerts
Biden’s First 100 Days: Policy Changes & Your Industry
Alerts
What Should Pharma Companies Expect From the Biden Administration?
Health Care Counsel Blog
Second Judge Grants Temporary Injunction Against Favored Nation Rule
Health Care Counsel Blog
Early Christmas Presents for Pharmaceutical Manufacturers: Court Grants Temporary Ban on Medicare Part B Most Favored Nations Reimbursement Rule
Health Care Counsel Blog
Discount Safe Harbor Final Rule Released: OIG Seeks to Adopt Major Changes
Health Care Counsel Blog
CMS Releases Interim Final Rule Establishing Reimbursement for Part B Drugs Based on International Pricing
Events
Medicare Pricing and Rebate Essentials and Advanced CMS Pricing and Rebate Topics
Health Care Counsel Blog
OIG Issues Fraud Alert: Should Pharma and Device Companies Cease Speaker Programs?